Intravitreal Bevacizumab Followed by Ranibizumab for Neovascular Age Related Macular Degeneratıon
Journal Title: International Journal of Stem Cell Research and Transplantation (IJST) - Year 2014, Vol 2, Issue 4
Abstract
Purpose: To compare the outcomes after switching from intravitreal bevacizumab (IVB) to intravitreal ranibizumab (IVR) in patients with neovascular age related macular degeneration (ARMD). Material and Methods: A retrospective review of patients with neovascular ARMD, who were switched from treatment with Pro Re Nata (PRN) IVB to PRN IVR, was conducted in a university clinic. IVB (1.25 mg/0.05 ml) and IVR (0.5 mg/0.05 ml) were used. Retreatment criteria were defined based on an activity scoring (AS) system developed in our clinic. An AS was calculated for each lesion at each visit. AS results and the number of injections before and after switching treatment to IVR were compared.
Authors and Affiliations
Nilay Yuksel
Keywords
Related Articles
- EP ID EP197547
- DOI 10.19070/2332-290X-140007
- Views 99
- Downloads 0
Photo Documentation In Ocular Trauma
Objective: Aim of the study is to photograph different cases of ocular trauma to ensure the safety of an ophthalmologist in giving prognosis and avoiding problems which are faced in court of law in criminal cases. Study...
Re-Engraftment of Prior Cord Blood Graft in a Patient with Relapsed/Refractory Acute Myeloid Leukaemia following Haploidentical Transplantation
We report the case of a 32-year-old man with poor risk acute myeloid leukemia (AML) who received transplantation of an UCB graft following myeloablative conditioning but unfortunately relapsed after one year with complet...
Role of Stem Cells in Cardiac Diseases
Ischemic heart disease is the leading cause of global mortality, and cardiovascular diseases represent a major challenge for researchers because of the overall health complications associated with them. Numerous studies...
Xenotransplantation for Renal Failure Patients: Evolution of Strategies
Xenotransplantation for Renal Failure Patients: Evolution of Strategies
Intravitreal Bevacizumab Followed by Ranibizumab for Neovascular Age Related Macular Degeneratıon
Purpose: To compare the outcomes after switching from intravitreal bevacizumab (IVB) to intravitreal ranibizumab (IVR) in patients with neovascular age related macular degeneration (ARMD). Material and Methods: A retrosp...